Gabriela García

Gabriela García

Auto-generated profile, based on publicly available information

Gabriela García

Sociedad Ecuatoriana de Reumatología, Guayaquil, Ecuador

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Respirar
Verified
Journal Article
Open access
PDF file
SVSara Vargas
Sara Vargas
MJMayra Castillo Jurado
Mayra Castillo Jurado
MNMaría Belen Noboa-Sevilla
María Belen Noboa-Sevilla
CECarlos Encalada
Carlos Encalada
GGGabriela García
Gabriela García
Jacobo Sellares TorresJacobo Sellares Torres
Jacobo Sellares Torres
Introduction: Interstitial lung disease (ILD) is a common and high-impact manifestation in patients with systemic autoimmune rheumatic diseases (SARDs). Timely detection requires clinical tools based on evidence and multidisciplinary consensus. Methods: A multidisciplinary team developed the consensus for the screening and diagnosis of ILD-SARDs through the formulation of PICO clinical questions, a systematic literature review (2017–2023) reported in accordance with the PRISMA statement, evaluation of the evidence using the GRADE system, and the formulation of clinical practice recommendations, which were validated using the Delphi methodology. Results: Twelve key recommendations were established for the screening and diagnosis of interstitial lung disease (ILD) in patients with Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome (SS), Mixed Connective Tissue Disease (MCTD) and Idiopathic Inflammatory Myopathies (IIM). The use of high-resolution computed tomography (HRCT) and pulmonary function tests is highlighted as fundamental diagnostic tools. Respiratory assessment is recommended at each visit, along with active surveillance of fibrotic progression risk in diagnosed patients. Routine lung biopsy is not suggested, except in cases of suspected malignancy or discordant diagnoses. Conclusion: The implementation of evidence-based recommendations for the screening and diagnosis of ILD-SARDs aims to improve early detection, multidisciplinary intervention and patient prognosis. Their adoption can help standardize clinical practices and optimize care across all levels of the healthcare system.